Mesa Laboratories INC /CO/ Form 4 insider transactions

Mesa Laboratories CFO John Sakys reports the acquisition of 8,351 Restricted Stock Units (RSUs) on June 18, 2024, vesting in three annual installments.

Gary Owens, President and CEO of Mesa Laboratories, reports the disposition of common stock and derivative securities, including Restricted Stock Units (RSUs), on June 14 and 15, 2024.

Brian David Archbold, SVP Operations at Mesa Laboratories, reports the disposition and acquisition of common stock and restricted stock units on June 14, 2024.

John Sakys, CFO of Mesa Laboratories, reports the vesting and disposal of restricted stock units and common stock transactions.

Director John James Sullivan reports the expiration of non-qualified stock options in Mesa Laboratories Inc.

CFO of Mesa Laboratories, John Sakys, reports the expiration of unexercised non-qualified stock options.

Gary Owens, President and CEO of Mesa Laboratories, reports the expiration of unexercised non-qualified stock options.

Brian David Archbold, SVP Operations at Mesa Laboratories, reports the expiration of unexercised non-qualified stock options.

Brian David Archbold, SVP Operations at Mesa Laboratories, reports the expiration of unexercised non-qualified stock options.